promising new findings controversial experimental drug called interleukin cure for cancer will published april issue prestigious new england journal medicine according wall street analyst has obtained advance copy magazine among interleukin principal makers cetus corp headquartered emeryville calif and immunex corp based seattle wash journal released today contains two articles reporting high remission rates several cancer types journal also contains signed editorial concluding new results mark significant milestone search for successful immunotherapy for cancer interleukin also known substance naturally produced living cells laboratory drug controversial because was widely praised promising cancer treatment early reports its effectiveness 1985 only under criticism year later for its failure live its promise and due its ravaging side effects new studies conducted william west biotherapeutics inc franklin tenn particularly significant because found far fewer harsh side effects after changed way which drug administered study researchers administered cancer patients and found pct remission rate for kidney cancers and pct remission rate for melanoma type skin cancer according prudential bache securities stuart weisbrod obtained advance copy magazine for rectal and colon cancer researchers found remissions but none patients treated had side effects serious enough placed under intensive hospital care according article second study whose principal author steven rosenberg national cancer institute researchers administered 157 cancer patients and found pct remission rate cancers kidney pct rate melanomas and pct rate cancers colon and rectum national cancer institute trials total four patients died magazine reported confirming harshness drug side effects originally administered perhaps end search for successful immunotherapy for cancer said editorial signed john durant philadelphia chase cancer center these observations reported rosenberg and west surely did not describe successful practical approaches ready for widespread applications therapy cancer patients editorial said hand reflect seems possible successful manipulation cellular immune system then may near end search for meaningful direction immunuotherapy cancer editorial concluded reuter 